JNJ and SNN Deal Collapses Amid Leadership Dispute
Johnson & Johnson and Smith & Nephew abandoned discussions regarding a proposed $34 billion medical technology merger following disagreements over executive leadership structure. On Friday, October 23, 2026, reporting clarified that negotiations dissolved over control of the combined entity.
If merger talks break down over governance, watch for potential alternative capital deployment or asset sales within its orthopedics portfolio. Track for independent operational updates as standalone guidance takes precedence.